The Effect of Hysterotomy Technique on the Rate of Large Defects in the Hysterotomy Scar
NCT ID: NCT01091181
Last Updated: 2018-05-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
122 participants
INTERVENTIONAL
2009-10-31
2017-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparative Study Between Hormonal and Hysteroscopic Management of Cesarean Scar Defect
NCT06529952
Combined Hystroscopic and Laparoscopic Repair of CS Scar Disorder
NCT07183501
Effectiveness of Three Steps Hysteroscopic Repair of Post Caesarean Isthmocele in Patients With Post Menstrual Spotting
NCT05062551
Clinical Impact of Uterine Repair During Cesarean Section with Barbed Suture on the Incidence of Isthmocele
NCT06691750
Effects of Hysteroscopy and Transvaginal Surgery on Reproductive Prognosis in Patients With Post Cesarean Scar Defect
NCT04096677
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The aim is to compare two surgical techniques (different ways of opening the uterus), to investigate whether one or the other technique leads to fewer defective scars in the uterus. Both these techniques are in use at the clinic. After the operation, patients are cared for in the normal way.
Six months after the Caesarean, patients are examined using vaginal ultrasound. Vaginal ultrasound allows to see if the scar after the Caesarean has healed well, or if there are defects in it.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
high incision group
hysterotomy at cesarean performed 2 cm above plica vesicouterina
hysterotomy at cesarean
incision to open the uterus at cesarean.
low incision group
hysterotomy at cesarean performed 2 cm below plica vesicouterina
hysterotomy at cesarean
incision to open the uterus at cesarean.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
hysterotomy at cesarean
incision to open the uterus at cesarean.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* gestational age ≥ 37 gestational weeks
* cervical dilatation ≥5 cm,
* no previous uterine surgery other than cone biopsy, loop electrosurgical excision procedure, dilatation and curettage, or dilatation and evacuation, undergoing emergency caesarean section.
Exclusion Criteria
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Region Skane
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Olga Vikhareva, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Skane University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Skåne University Hospital Malmö
Malmo, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2-valentin
Identifier Type: -
Identifier Source: org_study_id
NCT03498339
Identifier Type: -
Identifier Source: nct_alias
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.